These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11730818)

  • 1. Studies on the plasma lipid profiles, and LCAT and CETP activities according to hyperlipoproteinemia phenotypes (HLP).
    Lee M; Kim JQ; Kim J; Oh H; Park M
    Atherosclerosis; 2001 Dec; 159(2):381-9. PubMed ID: 11730818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of bezafibrate therapy on subfractions of plasma low-density lipoprotein and high-density lipoprotein, and on activities of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in patients with hyperlipoproteinemia.
    Homma Y; Ozawa H; Kobayashi T; Yamaguchi H; Sakane H; Mikami Y; Mikami Y; Nakamura H
    Atherosclerosis; 1994 Apr; 106(2):191-201. PubMed ID: 8060379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
    Chung BH; Segrest JP; Franklin F
    Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
    Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H
    Artery; 1993; 20(1):1-18. PubMed ID: 8447724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired suppression of plasma free fatty acids and triglycerides by acute hyperglycaemia-induced hyperinsulinaemia and alterations in high density lipoproteins in essential hypertension.
    Ligtenberg JJ; Van Tol A; Van Haeften TW; Sluiter WJ; Reitsma WD; Dullaart RP
    J Intern Med; 1996 Oct; 240(4):233-42. PubMed ID: 8918515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities in growth hormone deficient and acromegalic men: role in altered high density lipoproteins.
    Beentjes JA; van Tol A; Sluiter WJ; Dullaart RP
    Atherosclerosis; 2000 Dec; 153(2):491-8. PubMed ID: 11164439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesteryl ester transfer and cholesterol esterification in type 1 diabetes: relationships with plasma glucose.
    Chang CK; Tso TK; Snook JT; Huang YS; Lozano RA; Zipf WB
    Acta Diabetol; 2001; 38(1):37-42. PubMed ID: 11487175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hepatic HDL-related mRNAs on plasma prebeta HDL in cholesterol-fed rabbits.
    Sugano M; Makino N; Yanaga T
    Artery; 1997; 22(4):182-205. PubMed ID: 9576025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein.
    Riemens S; van Tol A; Sluiter W; Dullaart R
    Atherosclerosis; 1998 Sep; 140(1):71-9. PubMed ID: 9733217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies in asymptomatic primary hyperlipidaemia. IV. ECG at rest and during exercise and its relation to various lipoprotein classes.
    Olsson AG; Ekelund LG; Carlson LA
    Acta Med Scand; 1975; 198(1-2):55-73. PubMed ID: 170796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody. Effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma.
    Yen FT; Deckelbaum RJ; Mann CJ; Marcel YL; Milne RW; Tall AR
    J Clin Invest; 1989 Jun; 83(6):2018-24. PubMed ID: 2723070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetic study of Finns with hypoalphalipoproteinemia and hyperalphalipoproteinemia: a novel Gly230 Arg mutation (LCAT[Fin]) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels.
    Miettinen HE; Gylling H; Tenhunen J; Virtamo J; Jauhiainen M; Huttunen JK; Kantola I; Miettinen TA; Kontula K
    Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):591-8. PubMed ID: 9555865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of fish oils on plasma lipid risk factors and esterified fatty acids in primary hyperlipoproteinemia].
    Zák A; Zeman M; Tvrzická E
    Sb Lek; 1997; 98(3):213-24. PubMed ID: 9601814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects.
    Ambrosch A; Mühlen I; Kopf D; Augustin W; Dierkes J; König W; Luley C; Lehnert H
    Diabetes Care; 1998 Dec; 21(12):2077-84. PubMed ID: 9839097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The importance of plasma lipids and apolipoproteins in the assessment of risk of myocardial infarction in the most common types of primary hyperlipoproteinemias].
    Zeman M; Zák A; Vítková D; Dusek F
    Cas Lek Cesk; 1991 Nov; 130(20-21):601-5. PubMed ID: 1769056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance.
    Escolà-Gil JC; Julve J; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
    J Lipid Res; 2001 Feb; 42(2):241-8. PubMed ID: 11181754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on LCAT, PLTP, and CETP in plasma and peripheral lymph in humans.
    Kujiraoka T; Nanjee MN; Oka T; Ito M; Nagano M; Cooke CJ; Takahashi S; Olszewski WL; Wong JS; Stepanova IP; Hamilton RL; Egashira T; Hattori H; Miller NE
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1653-9. PubMed ID: 12893687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E alleles and hyperlipoproteinemia in Japan.
    Eto M; Watanabe K; Ishii K
    Clin Genet; 1988 Oct; 34(4):246-51. PubMed ID: 3233777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesteryl ester transfer protein (CETP), HDL capacity of receiving cholesterol and status of inflammatory cytokines in patients with severe heart failure.
    Martinelli AEM; Maranhão RC; Carvalho PO; Freitas FR; Silva BMO; Curiati MNC; Kalil Filho R; Pereira-Barretto AC
    Lipids Health Dis; 2018 Oct; 17(1):242. PubMed ID: 30342531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific reduction of plasma large, light low-density lipoprotein by a bile acid sequestering resin, cholebine (MCI-196) in type II hyperlipoproteinemia.
    Homma Y; Kobayashi T; Yamaguchi H; Ozawa H; Sakane H; Nakamura H
    Atherosclerosis; 1997 Mar; 129(2):241-8. PubMed ID: 9105567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.